Innovation

Form Energy Raises $750 Million Series G As Iron-Air Battery Backlog Jumps To 80 GWh

By Amit Chowdhry ● Aug 16, 2026

Form Energy has raised $750 million in Series G financing to accelerate manufacturing of its multi-day iron-air battery systems and support a commercial backlog that has expanded from approximately 20 gigawatt-hours to 80 gigawatt-hours. T. Rowe Price led the round after also leading Form Energy’s previous Series F financing. New investors participating in the Series G include Sequoia Capital, Janus Henderson, Franklin Templeton, and PEAK6 Investments. The latest investment brings Form Energy’s total equity funding to more than $2 billion.

Copenhagen Infrastructure Partners Closes $3 Billion Growth Markets Fund II, Tripling Prior Fund Size

By Amit Chowdhry ● Aug 16, 2026

Copenhagen Infrastructure Partners has closed its second Growth Markets Fund with approximately $3 billion in commitments, nearly tripling the size of the strategy’s first vintage as the firm expands investment in large-scale energy infrastructure across high-growth emerging markets.

Corma Raises $60 Million Seed To Build Defensive Cybersecurity Foundation Model As AI Attackers Hit 88% Success Rate

By Amit Chowdhry ● Aug 16, 2026

Corma has raised $60 million in seed funding to build a foundation model specifically for defensive cybersecurity, targeting a widening gap between rapidly advancing AI-powered attacks and the ability of existing security systems to detect and stop them. Sequoia Capital led the financing, with participation from Khosla Ventures and Coatue.

DoorDash: Dot Robots Could Handle A High-Single-Digit Share Of Orders In Largest Test Market By Year-End

By Amit Chowdhry ● Aug 16, 2026

DoorDash is expanding its autonomous delivery efforts and expects its Dot ground robots to handle a high single-digit percentage of orders in the company’s largest test market by the end of 2026, offering an early indication of how automation could eventually complement its large human delivery network.

Capri: Jimmy Choo Operating Income More Than Triples As Michael Kors Gross Margin Expands 280 Basis Points And Company Net Debt Falls To $224 Million

By Amit Chowdhry ● Aug 16, 2026

Capri Holdings is showing signs of improving profitability across its remaining luxury portfolio even as overall revenue remains under pressure, with Jimmy Choo operating income more than tripling, Michael Kors gross margin expanding 280 basis points and companywide net debt falling from approximately $1.5 billion to $224 million in one year.

Flutter Targets Another $500 Million Of Cost And Capex Savings By 2029 As Prediction-Market Business Could Generate $50 Million In 2026

By Amit Chowdhry ● Aug 16, 2026

Flutter Entertainment has launched the second phase of a broad cost transformation program targeting another $500 million in gross operating-cost and capital-expenditure savings by 2029, while its growing prediction-market operations are already expected to generate about $50 million in market-making revenue in 2026.

Diodes Posts Sixth Consecutive Quarter Of Double-Digit Revenue Growth As AI Server Content Expands

By Amit Chowdhry ● Aug 16, 2026

Diodes Incorporated delivered its sixth straight quarter of double-digit year-over-year revenue growth as higher semiconductor content in AI server, automotive, and industrial applications helped Q2 revenue rise more than 20%.

Dine Brands: IHOP-Applebee’s Dual-Branded Locations Nearly Quadruple To 81

By Amit Chowdhry ● Aug 16, 2026

Dine Brands Global expanded its portfolio of combined IHOP-Applebee’s restaurants to 81 locations by the end of Q2 2026, nearly quadrupling the 21 dual-branded restaurants operating a year earlier as the company makes the format an increasingly important component of its long-term growth strategy.

Shake Shack Opens 27 Locations In Q2 As System-Wide Sales Reach $625.8 Million And First-Half Property Investment Hits $104.9 Million

By Amit Chowdhry ● Aug 16, 2026

Shake Shack opened 27 new restaurants in Q2 2026 as system-wide sales rose 13.8% to $625.8 million, while the company invested $104.9 million in property and equipment in the first half as it continued to accelerate expansion of its restaurant footprint.

Delek: Refining EBITDA Surges Nearly Fivefold To $566.2 Million As Crack Spreads Rise 136%

By Amit Chowdhry ● Aug 16, 2026

Delek US Holdings’ refining adjusted EBITDA surged nearly fivefold to $566.2 million in Q2 2026 from $114.8 million a year earlier as substantially stronger refining margins and a 136% increase in benchmark crack spreads transformed the economics of its downstream operations.

Vanda Prepares BYSANTI Launch As Patent Protection Extends To 2044

By Amit Chowdhry ● Aug 16, 2026

Vanda Pharmaceuticals is preparing to commercially launch BYSANTI during the second half of 2026 following FDA approval for bipolar I disorder and schizophrenia, with the therapy protected by data exclusivity into 2031 and patents extending as far as May 2044.

Energy Recovery Opens Saudi Manufacturing Plant With Full-Scale Operations Targeted By H1 2028

By Amit Chowdhry ● Aug 16, 2026

Energy Recovery has opened a new manufacturing facility in Saudi Arabia that will ultimately produce its full line of pressure exchangers, with the company targeting full-scale operations during the first half of 2028 as it moves production closer to one of the world’s largest desalination markets.

Expedia Raises 2026 Revenue Outlook To As Much As $16.22 Billion After 14% Q2 Growth

By Amit Chowdhry ● Aug 16, 2026

Expedia Group raised its 2026 revenue outlook to as much as $16.22 billion after Q2 revenue increased 14% year-over-year to $4.315 billion, with strong B2B growth, margin expansion and higher cash generation allowing management to lift several components of its full-year forecast.

Global Payments Operating Margin Reaches 42% In First Full Quarter As Pure-Play Commerce Company

By Amit Chowdhry ● Aug 16, 2026

Global Payments generated a 42% normalized adjusted operating margin in Q2 2026, up 70 basis points year over year, in its first full quarter operating as a pure-play commerce solutions provider following the Worldpay acquisition and the disposition of its Issuer Solutions business.

NuScale Partner Advances TVA Talks For Potentially Largest Nuclear Deployment Program In U.S. History

By Amit Chowdhry ● Aug 16, 2026

NuScale Power's exclusive global strategic partner ENTRA1 Energy is continuing discussions with the Tennessee Valley Authority toward a definitive power purchase agreement for what NuScale says could become the largest nuclear power deployment program in U.S. history.

Lucid Diagnostics Secured First Laboratory Benefit Manager Coverage Policy For EsoGuard During Q2

By Amit Chowdhry ● Aug 16, 2026

Lucid Diagnostics secured its first laboratory benefit manager coverage policy for EsoGuard during Q2 2026, giving the esophageal precancer diagnostic a pathway to coverage across multiple commercial health plans as the company continues to await a potential Medicare coverage decision.

Amplifica Raises $26 Million Series B To Advance Injectable Hair Regrowth Therapies

By Amit Chowdhry ● Aug 16, 2026

Amplifica Holdings Group has raised $26 million in an oversubscribed Series B financing to advance a pipeline of injectable treatments designed to reactivate dormant hair follicles and stimulate new hair growth. Tasso Partners led the round, with participation from Eli Lilly and Company, principals of Scopia Capital Management, and other new and existing investors.

Anthropic Reportedly In Talks To Acquire Decart AI For About $6 Billion

By Amit Chowdhry ● Aug 16, 2026

Anthropic is reportedly in talks to acquire Nvidia-backed Decart AI in a potential deal valued at about $6 billion, as the Claude developer looks to expand its computing capabilities and meet growing demand ahead of a potential public listing, according to Bloomberg. The discussions remain at an early stage, and there is no guarantee that a transaction will be completed.

Alex Cooper’s Unwell Reportedly Raises First Outside Funding At $500 Million Valuation From WTSL

By Amit Chowdhry ● Aug 15, 2026

Unwell, the media and entertainment company co-founded by "Call Her Daddy" host Alex Cooper and producer Matt Kaplan, has raised its first outside funding at a $500 million pre-money valuation as it looks to expand through acquisitions, investments and new business lines, according to Bloomberg.

Jasper-Kira Combination Creates Three-Asset Immunology Pipeline As $132 Million Financing Extends Runway Into H2 2028

By Amit Chowdhry ● Aug 15, 2026

Jasper Therapeutics has completed its acquisition of Kira Pharmaceuticals, creating a combined clinical-stage immunology company with three major development programs and access to resources in both the United States and China, while a concurrent $132 million financing is expected to fund planned operations through the second half of 2028.

Canton Strategic Super Validator Weight Could Increase 30-Fold Through 2028 As Locking Service Generates $1.3 Million

By Amit Chowdhry ● Aug 15, 2026

Canton Strategic Holdings could increase its active Super Validator weight as much as 30-fold through the first quarter of 2028 as the company scales its role within the Canton Network and begins generating meaningful operating revenue from a new Canton Coin locking service.

Lantern Pharma Says AI Cuts First-In-Human Drug Development Cost To $2 Million-$3 Million

By Amit Chowdhry ● Aug 15, 2026

Lantern Pharma says its artificial intelligence-driven drug development model has enabled the company to advance new oncology programs from initial AI-derived insights to first-in-human clinical trials for approximately $2 million to $3 million per program, substantially below what management describes as typical industry development costs.

LanzaTech’s Operating Expenses Fall 67% As Adjusted EBITDA Loss Improves 74%

By Amit Chowdhry ● Aug 15, 2026

LanzaTech reduced second-quarter operating expenses by 67% year over year as an extensive cost-reduction and organizational restructuring program helped the carbon management company narrow its adjusted EBITDA loss by about 74%.

Rein Therapeutics RENEW Trial Enrollment Runs Ahead Of Schedule As R&D And G&A Spending Decline

By Amit Chowdhry ● Aug 15, 2026

Rein Therapeutics has surpassed 25% enrollment in its global Phase 2 RENEW trial of LTI-03 for idiopathic pulmonary fibrosis, with enrollment running ahead of schedule and interim clinical data still expected during the second half of 2026 as the company simultaneously reduces R&D and administrative spending.

StablecoinX Cross-Chain Infrastructure Surpasses $3 Billion Of Verified Volume As ENA Treasury Reaches $218.4 Million

By Amit Chowdhry ● Aug 15, 2026

StablecoinX's cross-chain infrastructure has surpassed $3 billion in cumulative verified volume as the newly public stablecoin infrastructure company builds operating businesses around an ENA treasury representing approximately 20% of the token’s total supply.

Teamshares’ Portfolio Reaches $560 Million Of Pro Forma Revenue

By Amit Chowdhry ● Aug 15, 2026

Teamshares' trailing-12-month pro forma revenue reached approximately $560 million at the end of the second quarter of 2026 as the newly public company continues building a diversified portfolio of small and midsized businesses through its programmatic acquisition strategy.

Sigma Lithium Plans To More Than Double Capacity To 830,000 Tons By 2028 As EBITDA Margin Reaches Record 47%

By Amit Chowdhry ● Aug 15, 2026

Sigma Lithium plans to increase installed lithium oxide concentrate capacity to approximately 830,000 tons annually by the end of 2028, as record second-quarter profitability, lower production costs, and improving operating productivity support a multi-stage expansion of its Brazilian operations.

Suncrete Maintains Up To $480 Million Revenue Outlook Despite Wet Weather

By Amit Chowdhry ● Aug 15, 2026

Suncrete maintained its fiscal 2026 revenue outlook of $420 million to $480 million as strong construction demand across the U.S. Sunbelt and contributions from recent acquisitions helped offset unusually wet weather during the second quarter.

Replimune Raises $150 Million To Fund TUDRIQEV Launch And Confirmatory Trial

By Amit Chowdhry ● Aug 15, 2026

Replimune completed a $150 million financing as the biotechnology company prepares to commercially launch TUDRIQEV following FDA accelerated approval and continues the Phase 3 confirmatory trial required to support the treatment’s longer-term regulatory position.

Americas Gold And Silver Plans $45 Million To $60 Million Of Growth And Exploration Spending

By Amit Chowdhry ● Aug 15, 2026

Americas Gold and Silver plans approximately $45 million to $60 million of combined growth and exploration capital during 2026 as the company increases production capacity at its Galena Complex and conducts what management describes as the largest drilling campaign in its history.